African Journal of Virology Research

ISSN 2756-3413

African Journal of Virology Research ISSN 2756-3413 Vol. 16 (7), pp. 001-005, July, 2022. © International Scholars Journals

Full Length Research Paper

Seroprevalence of anti SARS-CoV-2 antibody among asymptomatic and apparently healthy individuals attending in the department of microbiology, Dhaka Medical College

Maherun Nesa a , Rubaiya Binte Kabira, Farjana Binte Habib a, Rizwana Zamana, Noor-E-Jannat Taniaa, Azmeri Haquea, Nusrat Noor Tanni a, Akhtaruzzaman Chowdhurya, Nazmun Sharmina, Kakali Halderb, Mahbuba Chowdhuryc, Sultana Sajeda Nahar c, Mizanur Rahmand, Sazzad Bin Shahidd, S. M. Shamsuzzamane,*

 a, b ,c  ,d,*e Department of Microbiology, Dhaka Medical College, Shahbag-1000, Dhaka, Bangladesh.

Accepted 17 July, 2022 

Abstract

Objectives: SARS-CoV-2 is an emerging corona virus, was first recognized as the causative agent of COVID-19 and WHO declared COVID-19 as a global pandemic. For better control of COVID-19 pandemic, identifying and quarantining of asymptomatic individuals are urgently needed. The objective of study was to determine the Anti SARS-CoV-2 antibody (IgG) among asymptomatic and apparently healthy individuals attending the department of microbiology, Dhaka Medical College. Methods: Blood samples were collected from asymptomatic and apparently healthy individuals attending the department of microbiology, Dhaka Medical College. Antibody responses were measured using the Chemiluminescence Immunoassay, ADVIA Centaur (Siemens, Munich, Germany) SARS-CoV-2 IgG (COV2G) assay. Results: Among 200 blood samples, 49% were from male and 51% were from female. Out of 200 samples, 39% showed reactive results for anti SARS-Cov-2 IgG assay. Most of the participants were from 21-40 years of age and 41-60 years of age group (52%) were mostly affected. We did not observe significant differences in seroprevalence between gender and age. Conclusion: The results will help to know the percentage of population having anti SARS-Cov-2 antbodies which may help the policy makers to control pandemic and make policy regarding vaccination strategy. 

Key words: Anti SARS-CoV-2 antibody; Asymptomatic; Bangladesh; IgG, SARS-CoV-2; Covid-19; Seroprevalence.


Download Full Text - PDF

Mizanur Rahman on Google Scholar Mizanur Rahman on Pubmed Nusrat Noor T on Google Scholar Nusrat Noor T on Pubmed Kakali H on Google Scholar Kakali H on Pubmed Mahbuba C on Google Scholar Mahbuba C on Pubmed Rizwana Z on Google Scholar Rizwana Z on Pubmed Sultana SN on Google Scholar Sultana SN on Pubmed Azmeri H on Google Scholar Azmeri H on Pubmed Akhtaruzzaman C on Google Scholar Akhtaruzzaman C on Pubmed Maherun N on Google Scholar Maherun N on Pubmed Farjana BH on Google Scholar Farjana BH on Pubmed Nazmun S on Google Scholar Nazmun S on Pubmed Noor-E-Jannat T on Google Scholar Noor-E-Jannat T on Pubmed Sazzad BS and S. M. Shamsuzzaman* on Google Scholar Sazzad BS and S. M. Shamsuzzaman* on Pubmed Rubaiya BK on Google Scholar Rubaiya BK on Pubmed